FINWIRES · TerminalLIVE
FINWIRES

Jazz Pharmaceuticals Has Several Growth Options Beyond Marketed Drugs, RBC Says

By

Jazz Pharmaceuticals (JAZZ) has a number of options that could add meaningful growth over the coming years beyond the company's currently marketed drugs, RBC Capital Markets said in a Friday research note.

Building on this, RBC favors the internal development of an orexin receptor agonist, although reviving development of its suvecaltamide essential-tremor treatment, entering the psychedelics space, or building on its brain-cancer business could also add value, according to the note.

Pursuing an internal orexin program and expanding the glioma franchise would yield internal synergies, and the balance-sheet savings from developing an orexin program internally could be used to bolt on a glioma drug for relatively low cost, RBC said.

Additionally, RBC said the relatively limited research-and-development investment required for some late-stage psychedelic programs could benefit Jazz Pharmaceuticals because it could allow for nearer-term revenue accretion.

RBC reiterated its outperform rating and maintained its $258 price target on the company's stock.

Price: $252.24, Change: $-6.14, Percent Change: -2.38%

Related Articles

Wire

Update: BHP Group Faces Strike Action in Western Australia's Pilbara

(Updates to add BHP's statement in the fourth and fifth paragraphs and share movement in the last paragraph)BHP Group (ASX:BHP) is facing another strike from members of three unions in Western Australia's Pilbara region who have decided to impose a 24-hour ship-loading ban on Aug. 8 and will also down tools on Aug. 9, according to multiple media reports on Friday.According to an Australian Financial Review report, the company expects that a work stoppage at Port Hedland will impact AU$120 million in revenue per day.The combined union decision comes after a failed strike over pay disputes that took place on July 16, which was not attended by enough workers to cause a serious disruption.In response to' request for comment, a BHP spokesperson said that the company has plans in place to continue operations despite the potential disruptions.The company has a formal meeting convened by the Fair Work Commission scheduled for next Tuesday to progress bargaining and will seek further assistance from the Commission if needed, the spokesperson added.The company's shares rose almost 2% in recent Friday trade.

ASX:BHP
Wire

Cohu Q2 Adjusted Earnings, Revenue Rise; Shares Jump After Hours

Cohu (COHU) reported Q2 adjusted earnings late Thursday of $0.26 per diluted share, up from $0.02 a year earlier.Analysts polled by FactSet expected $0.14.Revenue for the quarter ended June 27 rose to $149 million from $107.7 million a year ago.Analysts projected $144.2 million.Cohu expects Q3 revenue of $170 million, plus or minus $7 million.Analysts project $146.4 million.Cohu shares jumped 21% in after-hours trading.

$COHU
Wire

Western Union Q2 Adjusted Earnings, Revenue Fall; Cuts 2026 Outlook

Western Union (WU) reported Q2 adjusted earnings Thursday of $0.31 per diluted share, down from $0.42 a year earlier.Analysts polled by FactSet expected $0.42.Revenue for the quarter ended June 30 was $1.01 billion, compared with $1.03 billion a year earlier.Analysts expected $1.02 billion.The company now expects 2026 adjusted EPS of $1.25 to $1.35, down from $1.75 to $1.85. Analysts expect $1.72.Full-year revenue is now expected to grow 3% to 5%, compared with 5% to 8% expected earlier.

$WU